Calendar

Tuesday Feb 3,2026
Estimate Eps
Actual Eps
Eps Surprise
Estimate Revenue
Actual Revenue
Revenue Surprise
Period
logo
MRK
Merck
2.01 USD
2.04 USD
+1.49%
16.21B USD
16.40B USD
+1.17%
Q4 2025
Backtest
The backtest results indicate that MRK shows weak short-term performance after earnings beats, with low win rates and slight negative returns within 3 to 10 days. However, over a 30-day horizon, MRK demonstrates a moderate positive return and improved win rate, suggesting a delayed market response. In contrast, the Pharmaceuticals Industry overall experiences a slight negative return on the event day, reflecting possible market skepticism or profit-taking. This implies that investors may benefit from holding MRK longer post-earnings beat, while exercising caution with broader industry trades immediately following earnings surprises.
logo
PEP
Pepsico
2.24 USD
2.26 USD
+0.89%
28.97B USD
29.34B USD
+1.29%
Q4 2025
logo
ETN
Eaton
3.32 USD
3.33 USD
+0.30%
7.09B USD
7.10B USD
+0.14%
Q4 2025
logo
PYPL
Paypal Holdings
1.29 USD
1.23 USD
-4.65%
8.79B USD
8.68B USD
-1.30%
Q4 2025
logo
ITW
Illinois Tool Works
2.69 USD
2.72 USD
+1.12%
4.06B USD
4.10B USD
+0.99%
Q4 2025
logo
TDG
TransDigm Group
8.04 USD
8.23 USD
+2.36%
2.25B USD
2.28B USD
+1.33%
Q1 2026
logo
EPD
Enterprise Products
0.69 USD
0.75 USD
+8.70%
12.36B USD
13.79B USD
+11.57%
Q4 2025
logo
GWW
W.W. Grainger
9.46 USD
9.44 USD
-0.21%
4.40B USD
4.43B USD
+0.68%
Q4 2025
logo
MPC
Marathon Petroleum
2.71 USD
4.07 USD
+50.18%
30.51B USD
33.42B USD
+9.54%
Q4 2025
logo
AME
Ametek
1.94 USD
2.01 USD
+3.61%
1.95B USD
2.00B USD
+2.56%
Q4 2025
logo
IT
Gartner
3.51 USD
3.94 USD
+12.25%
1.75B USD
1.80B USD
+2.86%
Q4 2025
logo
WTW
Willis Towers Watson
7.93 USD
8.12 USD
+2.40%
2.86B USD
2.94B USD
+2.80%
Q4 2025
logo
CHT
CHT
--
--
--
2.08B USD
--
--
Q4 2025
logo
BR
Broadridge Financial Solutions
1.36 USD
1.59 USD
+16.91%
1.60B USD
1.71B USD
+7.12%
Q2 2026
logo
ADM
Archer-Daniels-Midland
0.8 USD
0.87 USD
+8.75%
21.06B USD
18.56B USD
-11.87%
Q4 2025
logo
HUBB
Hubbell
4.72 USD
4.73 USD
+0.21%
1.49B USD
1.49B USD
+0.00%
Q4 2025